You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tumor Suppressor Gene 2 (TUSC2)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer Trial in Tampa, Houston (quaratusugene ozeplasmid, pembrolizumab, docetaxel)

Recruiting
  • Non Small Cell Lung Cancer
  • quaratusugene ozeplasmid
  • +3 more
  • Tampa, Florida
  • +2 more
Sep 12, 2022

DKI Combined With APT for Post-treatment Assessment of Ovarian

Not yet recruiting
  • Malignant Tumor of the Ovary
  • XRCC2 Gene Mutation
  • DKI and APT
  • (no location specified)
Nov 30, 2022

Small Cell Lung Cancer Extensive Stage Trial (quaratusugene ozeplasmid, atezolizumab)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • quaratusugene ozeplasmid
  • atezolizumab
  • (no location specified)
Jan 19, 2023

Solid Tumor Trial (TL118 Capsule)

Not yet recruiting
  • Solid Tumor
  • TL118 Capsule
  • (no location specified)
Aug 18, 2023

Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

Not yet recruiting
  • Metastatic Solid Tumor
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 12, 2023

Neuroblastoma Trial in Houston (SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 1 SKNLP, SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 2

Active, not recruiting
  • Neuroblastoma
  • SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 1 SKNLP
  • SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 2 SKNLP
  • Houston, Texas
    Texas Children's Hospital
Mar 3, 2022

AXIN1 Gene Mutation, APC Gene Mutation, Solid Tumor Trial (REC-4881)

Not yet recruiting
  • AXIN1 Gene Mutation
  • +2 more
  • (no location specified)
Aug 21, 2023

Metastatic Solid Tumor, SF3B1 Gene Mutation, Spliceosome Mutation Trial in Baltimore (Recommendation for treatment with

Recruiting
  • Metastatic Solid Tumor
  • +4 more
  • Recommendation for treatment with immunotherapy
  • Baltimore, Maryland
    Johns Hopkins University
Sep 8, 2022

Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Solid Tumor Trial (TYRA-300)

Not yet recruiting
  • Locally Advanced Urothelial Carcinoma
  • +3 more
  • (no location specified)
Sep 15, 2022

Prostate Cancer Recurrent Trial in Lexington (Hydroxychloroquine Sulfate 200Mg Tab)

Recruiting
  • Prostate Cancer Recurrent
  • Hydroxychloroquine Sulfate 200Mg Tab
  • Lexington, Kentucky
    Markey Cancer Center - University of Kentucky
Jul 6, 2021

Pancreas Cancer Trial (mRNA expression)

Not yet recruiting
  • Pancreas Cancer
  • mRNA expression
  • (no location specified)
Aug 8, 2022

NSCLC, Metastatic Non Small Cell Lung Cancer, Stage IV NSCLC Trial in Duarte, Minneapolis (Fludarabine, Cyclophosphamide, CISH

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +5 more
  • Duarte, California
  • +1 more
Dec 7, 2022

Solid Tumor, Adult, Intrahepatic Cholangiocarcinoma, Urothelial Carcinoma Trial in Taiwan, United States (KIN-3248)

Recruiting
  • Solid Tumor, Adult
  • +2 more
  • La Jolla, California
  • +4 more
Aug 9, 2022

Neuroblastoma Trial in Houston (Neuroblastoma Vaccine (unmodified SKNLP, with gene-modified SJNB-JF-IL2 and SJNB-JF-LTN

Active, not recruiting
  • Neuroblastoma
  • Neuroblastoma Vaccine (unmodified SKNLP, with gene-modified SJNB-JF-IL2 and SJNB-JF-LTN neuroblastoma cells
  • Cytoxan
  • Houston, Texas
    Texas Children's Hospital
Mar 25, 2022

Low-grade Glioma, IDH2 Gene Mutation, Recurrent Glioma Trial in Boston (Niraparib, Resection/Treatment with Niraparib)

Recruiting
  • Low-grade Glioma
  • +4 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 19, 2022

Diffuse Intrinsic Pontine Glioma, High Grade Glioma, Embryonal Tumor Trial in Houston ((C7R)-GD2.CART cells, Cyclophosphamide,

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • +3 more
  • (C7R)-GD2.CART cells
  • +2 more
  • Houston, Texas
    Texas Children's Hospital
Feb 7, 2022

Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Houston (HER2-specific T cells)

Recruiting
  • Brain Tumor, Recurrent
  • Brain Tumor, Refractory
  • HER2-specific T cells
  • Houston, Texas
  • +1 more
May 3, 2022

Circulating Tumor DNA-Guided Late-Line Treatment in Late-Stage

Completed
  • Metastatic Breast Cancer
  • +2 more
  • Control group
  • Case group
  • (no location specified)
Jun 16, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

Active, not recruiting
  • BRCA1 Gene Mutation
  • +9 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Molecular Profiling in Prostate Cancer

Recruiting
  • Prostate Cancer Metastatic
  • +4 more
  • Tumor molecular profiling
  • Athens, Greece
    Hellenic Cooperative Oncology Group
Mar 15, 2022

Solid Tumors, Adult, Solid Tumor, Mesothelioma (MPM) Trial in United States (IK-930)

Recruiting
  • Solid Tumors, Adult
  • +7 more
  • Boston, Massachusetts
  • +6 more
Jan 24, 2023

Lung Cancer Trial in Houston (DOTAP:Chol-TUSC2, Erlotinib, Dexamethasone)

Terminated
  • Lung Cancer
  • Houston, Texas
    UT MD Anderson Cancer Center
Feb 11, 2022

Gastrointestinal Epithelial Cancer, Gastrointestinal Tumors, Cancer of Gastrointestinal Tract Trial in Minneapolis

Recruiting
  • Gastrointestinal Epithelial Cancer
  • +10 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Aug 20, 2021

Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Urothelial Carcinoma AJCC v6 and v7, Stage III Bladder Urothelial

Not yet recruiting
  • Muscle Invasive Bladder Urothelial Carcinoma
  • +3 more
  • Biospecimen Collection
  • +7 more
  • (no location specified)
Aug 10, 2023

HER-2 Gene Amplification, HER2-positive Gastric Cancer, HER2-positive Breast Cancer Trial in United States (chimeric antigen

Recruiting
  • HER-2 Gene Amplification
  • +4 more
  • chimeric antigen receptor (CAR) T cell therapy
  • Duarte, California
  • +6 more
Aug 10, 2022